NetworkNewsBreaks – Vivos Therapeutics Inc. (NAS
Post# of 51
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild-to-moderate obstructive sleep apnea (“OSA”), has announced that it will participate at the Benzinga Biotech Small Cap Conference taking place from March 24-25, 2021. Vivos Chief Executive Officer, Kirk Huntsman, Chief Financial Officer, Brad Amman, and Investor Relations Officer, Ed Loew, will be presenting at the event with their presentation scheduled to begin at 11:40 a.m. EST on Thursday, March 25, 2021. Investors interested in joining the Vivos presentation can register for a free spectator pass at https://nnw.fm/P5Bro.
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer